185 related articles for article (PubMed ID: 24024664)
1. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy.
Cheng J; Chen J; Xie B; Wei HL
Toxicol Mech Methods; 2013 Nov; 23(9):678-83. PubMed ID: 24024664
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine reverses the drug resistance of leukemic K562/ADM cells by inhibiting autophagy.
Wang F; Zhang Z; Leung WT; Chen J; Yi J; Ying C; Yuan M; Wang M; Zhang N; Qiu X; Wang L; Wei H
Mol Med Rep; 2019 Oct; 20(4):3883-3892. PubMed ID: 31485616
[TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
4. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
Li WD; Zhang BD; Wei R; Liu JH; Lin ZB
Acta Pharmacol Sin; 2008 May; 29(5):620-7. PubMed ID: 18430371
[TBL] [Abstract][Full Text] [Related]
5. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
6. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
7. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
8. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy.
Cheng J; Wei HL; Chen J; Xie B
Toxicol Mech Methods; 2012 Sep; 22(7):512-9. PubMed ID: 22519831
[TBL] [Abstract][Full Text] [Related]
10. [Effect of phenylhexyl isothiocyanate on adriamycin resistance of K562/A02 cell line].
Yuang P; Chen BA; Cheng J; Ma XD; Liu DL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):352-7. PubMed ID: 19379565
[TBL] [Abstract][Full Text] [Related]
11. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
12. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
[TBL] [Abstract][Full Text] [Related]
13. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
[TBL] [Abstract][Full Text] [Related]
14. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
16. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
17. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
19. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
Ren JH; He WS; Nong L; Zhu QY; Hu K; Zhang RG; Huang LL; Zhu F; Wu G
Cancer Biother Radiopharm; 2010 Feb; 25(1):75-80. PubMed ID: 20187799
[TBL] [Abstract][Full Text] [Related]
20. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
